Abstract
Antioxidants inhibit the rat liver microsomal mixed-function-oxidase-catalysed hydroxylation of benzo[a]pyrene. These antioxidants also decrease the formation of mutagenic products from benzo[a]pyrene as judged by the Ames bacterial-mutagenicity assay [B.N. Ames, J. McCann & E. Yamazaki (1975) Mutat. Res. 31, 347-364]. It is suggested that antioxidants exert their protective effect against cancer by inhibiting the formation of carcinogenic metabolites.
Full text
PDF![473](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ee0/1164816/91e14a196147/biochemj00509-0196.png)
![474](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ee0/1164816/9ddf3aab07e5/biochemj00509-0197.png)
![475](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ee0/1164816/7c5f86370f15/biochemj00509-0198.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ames B. N., Mccann J., Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat Res. 1975 Dec;31(6):347–364. doi: 10.1016/0165-1161(75)90046-1. [DOI] [PubMed] [Google Scholar]
- Cantrell E., Abreu M., Busbee D. A simple assay of aryl hydrocarbon hydroxylase in cultured human lymphocytes. Biochem Biophys Res Commun. 1976 May 17;70(2):474–479. doi: 10.1016/0006-291x(76)91070-6. [DOI] [PubMed] [Google Scholar]
- Conney A. H. Pharmacological implications of microsomal enzyme induction. Pharmacol Rev. 1967 Sep;19(3):317–366. [PubMed] [Google Scholar]
- Cumming R. B., Walton M. F. Modification of the acute toxicity of mutagenic and carcinogenic chemicals in the mouse by prefeeding with antioxidants. Food Cosmet Toxicol. 1973 Aug;11(4):547–553. doi: 10.1016/s0015-6264(73)80325-6. [DOI] [PubMed] [Google Scholar]
- Grantham P. H., Weisburger J. H., Weisburger E. K. Effect of the antioxidant butylated hydroxytoluene (BHT) on the metabolism of the carcinogens N-2-fluorenylacetamide and N-hydroxy-N-2-fluorenylacetamide. Food Cosmet Toxicol. 1973 Apr;11(2):209–217. doi: 10.1016/s0015-6264(73)80487-0. [DOI] [PubMed] [Google Scholar]
- Lu A. Y., Coon M. J. Role of hemoprotein P-450 in fatty acid omega-hydroxylation in a soluble enzyme system from liver microsomes. J Biol Chem. 1968 Mar 25;243(6):1331–1332. [PubMed] [Google Scholar]
- McCann J., Choi E., Yamasaki E., Ames B. N. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc Natl Acad Sci U S A. 1975 Dec;72(12):5135–5139. doi: 10.1073/pnas.72.12.5135. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nemoto N., Gelboin H. V., Habig W. H., Ketley J. N., Jakoby W. B. K region benzo (alpha) pyrene-4,5-oxide is conjugated by homogeneous gluthathione S-transferases. Nature. 1975 Jun 5;255(5508):512–512. doi: 10.1038/255512a0. [DOI] [PubMed] [Google Scholar]
- Speier J. L., Wattenberg L. W. Alterations in microsomal metabolism of benzo[a]pyrene in mice fed butylated hydroxyanisole. J Natl Cancer Inst. 1975 Aug;55(2):469–472. [PubMed] [Google Scholar]
- Torrielli M. V., Slater T. F. Inhibition of NADPH-cytochrome c reductase by propyl gallate. Biochem Pharmacol. 1971 Aug;20(8):2027–2032. doi: 10.1016/0006-2952(71)90402-3. [DOI] [PubMed] [Google Scholar]
- Ulland B. M., Weisburger J. H., Yamamoto R. S., Weisburger E. K. Antioxidants and carcinogenesis: butylated hydroxytoluene, but not diphenyl-p-phenylenediamine, inhibits cancer induction by N-2-fluorenylacetamide and by N-hydroxy-N-2-fluorenylacetamide in rats. Food Cosmet Toxicol. 1973 Apr;11(2):199–207. doi: 10.1016/s0015-6264(73)80486-9. [DOI] [PubMed] [Google Scholar]
- Wattenberg L. W. Effects of dietary constituents on the metabolism of chemical carcinogens. Cancer Res. 1975 Nov;35(11 Pt 2):3326–3331. [PubMed] [Google Scholar]
- Wattenberg L. W. Inhibition of carcinogenic and toxic effects of polycyclic hydrocarbons by phenolic antioxidants and ethoxyquin. J Natl Cancer Inst. 1972 May;48(5):1425–1430. [PubMed] [Google Scholar]
- Wattenberg L. W. Inhibition of carcinogenic and toxic effects of polycyclic hydrocarbons by several sulfur-containing compounds. J Natl Cancer Inst. 1974 May;52(5):1583–1587. doi: 10.1093/jnci/52.5.1583. [DOI] [PubMed] [Google Scholar]
- Wattenberg L. W. Inhibition of chemical carcinogen-induced pulmonary neoplasia by butylated hydroxyanisole. J Natl Cancer Inst. 1973 Jun;50(6):1541–1544. doi: 10.1093/jnci/50.6.1541. [DOI] [PubMed] [Google Scholar]
- Yang C. S., Strickhart F. S. Inhibition of hepatic mixed function oxidase activity by propyl gallate. Biochem Pharmacol. 1974 Nov 15;23(22):3129–3138. doi: 10.1016/0006-2952(74)90598-x. [DOI] [PubMed] [Google Scholar]
- Yang C. S., Strickhart F. S., Woo G. K. Inhibition of the mono-oxygenase system by butylated hydroxyanisole and butylated hydroxytoluene. Life Sci. 1974 Oct 15;15(8):1497–1505. doi: 10.1016/0024-3205(74)90124-6. [DOI] [PubMed] [Google Scholar]